Baker Brothers Advisors - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 263 filers reported holding INTELLIA THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$6,055,000
+149.2%
111,296
-9.0%
0.02%
+130.0%
Q3 2020$2,430,000
-10.1%
122,238
-4.9%
0.01%
-16.7%
Q2 2020$2,702,000
+71.9%
128,5380.0%0.01%
+20.0%
Q1 2020$1,572,000
-16.6%
128,5380.0%0.01%0.0%
Q4 2019$1,886,000
+9.9%
128,5380.0%0.01%
-16.7%
Q3 2019$1,716,000
-18.4%
128,5380.0%0.01%
-14.3%
Q2 2019$2,104,000
-4.1%
128,5380.0%0.01%0.0%
Q1 2019$2,195,000
+25.1%
128,5380.0%0.01%0.0%
Q4 2018$1,755,000
-68.1%
128,538
-33.2%
0.01%
-61.1%
Q3 2018$5,510,000
-63.2%
192,538
-64.8%
0.04%
-67.9%
Q2 2018$14,964,000
-14.9%
546,922
-34.4%
0.11%
-24.8%
Q1 2018$17,585,000
-20.1%
833,795
-27.2%
0.15%
-22.0%
Q4 2017$22,016,000
-16.6%
1,145,453
+7.8%
0.19%
-10.7%
Q3 2017$26,394,000
+55.3%
1,062,1200.0%0.21%
+43.6%
Q2 2017$16,994,000
+13.6%
1,062,1200.0%0.15%
+22.1%
Q1 2017$14,965,000
+7.5%
1,062,1200.0%0.12%
-10.3%
Q4 2016$13,924,000
-23.0%
1,062,1200.0%0.14%
-17.1%
Q3 2016$18,077,000
-20.3%
1,062,1200.0%0.16%
-31.1%
Q2 2016$22,676,0001,062,1200.24%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Discovery Value Fund 561,561$17,756,5599.73%
MPM BioImpact LLC 544,639$17,221,4854.60%
Casdin Capital, LLC 1,178,075$37,250,7324.12%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,145,091$36,207,7773.72%
Atlas Venture Associates IX, LLC 10,000$316,2002.69%
Deep Track Capital, LP 2,000,000$63,240,0002.44%
ARK Investment Management 9,948,629$314,575,6382.41%
Merlin Capital, Inc 18,526$585,7922.19%
Orchard Capital Management, LLC 159,155$5,032,4811.86%
TANG CAPITAL MANAGEMENT LLC 397,600$12,572,1121.77%
View complete list of INTELLIA THERAPEUTICS INC shareholders